Medpal AI (LON: MPAL) says that the UK regulatory approval of the first oral GLP-1 receptor agonist tablet developed by Novo Nordisk has come earlier than expected and this will provide a boost for the company’s New Health weight management clinic. It broadens the potential market. The share price jumped 19.35% to 3.7p.
Pennant International (LON: PEN) has won another contract for its Auxilium software. It is a multi-year framework agreement with the Canadian Department of National Defence for integrated product support services. This replaces shorter-term contracts. It is estimated that the contract could be worth £1.6m each year, which is more than 10% of forecast 2027 revenues. The share price rebounded 10.6% to 26p.
Camellia (LON: CAM) has sold a substantial amount of its remaining South Asian art collection via auction for £14m after costs. Gross profit is £13.4m. The share price gained 4.21% to £55.75.
Hutchmed China Ltd (LON: HCM) has presented Sovleplenib ESLIM-2 phase III data in warm antibody autoimmune haemolytic anaemia in China. The study met its primary endpoint with a much higher reaction than to the placebo. The share price rose 3.4% to 175p.
FALLERS
Shares in Pri0R1Ty Intelligence (LON: PR1) halved to 0.85p when they returned from suspension. The AI software business generated revenues of £174,000 in the year to September 2025 and the underlying loss was £3.3m. Cash was £796,000 at the end of September 2025. More cash is required. So far this year contracted revenues are more than £400,000.
Virgin Wines (LON: VINO) says full year revenues are 4% ahead even though the wine retail market is down by one-fifth. The fourth quarter was slightly weaker than expected. Higher rent costs and lower interest income have led to an increase in forecast 2025-26 loss to £1.5m. Warehousing is being consolidated in Preston. Cavendish expects a lower loss in 2026-27 and forecast net cash of £4m at the end of June 2027 should be the low point. The share price declined 14.9% to 28.5p.
Aquis-quoted energy B (NRGB) is acquiring the 35% working interest in the Horse Hill oil field near Gatwick owned by UK Oil and Gas (UKOG), as well as the 77.9% shareholding in Horse Hill Developments. The combined interest in the relevant licences is 85.6%. The payment is £1m with an initial deposit of £100,000. The cash will be invested in UK salt cavern energy storage projects and other opportunities. The UKOG share price fell 10.3% to 0.00875p.
Fuel ingredients development Quadrise (LON: QED) reveals that there is a delay to the Valkor oil sands pilot plant until the end of 2026, when it was previously expected by the end of June. This means that the $950,000 licence fee should be received by the end of September, assuming project funding is agreed. The share price slipped 5.66% to 1.7925p.